FDA Approves Drug for Active Psoriatic Arthritis
July 6th 2017The FDA has approved Bristol-Myers Squibb’s abatacept (Orencia) in both intravenous (IV) and subcutaneous (SC) injections forms for the treatment of active Psoriatic Arthritis (PsA) in adults. The approval is the third autoimmune disease indication for Orencia.
Read More
FDA Orders Drug Compounding Company to Halt Operations
July 6th 2017FDA officials said that U.S. District Judge William H. Steele has entered a consent decree of permanent injunction against compounder Medistat RX, LLC, prohibiting the company from manufacturing or distributing products until it complies with appropriate regulations.
Read More